Nasdaq

Insulet Announces Omnipod® 5 System is Now Compatible with Abbott’s FreeStyle Libre 2 Plus Sensor in the U.S.

ACTON, Mass.--(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced ...
Nasdaq

Tandem Diabetes Care’s t:slim X2™ Insulin Pump is the First Automated Insulin Delivery System to Integrate with Abbott’s New FreeStyle Libre® 2 Plus Sensor

Abbott’s latest innovation, the FreeStyle Libre® 2 Plus sensor, is available for the first time for t:slim X2™ insulin pump users in the U.S. Tandem’s Control-IQ™ hybrid closed-loop technology now ...
Medscape

New FreeStyle Libre Glucose Monitoring System Gets EU Approval

The FreeStyle Libre 3 glucose monitoring system (Abbott) has been granted a CE mark for use by people with diabetes in the countries of the European Union (EU). The next-generation FreeStyle Libre 3 ...
Reuters

Abbott Receives Health Canada Authorization Under Interim Order To Use Freestyle® Libre System For Hospitalized Patients During Covid-19 Pandemic

* ABBOTT LABORATORIES - HEALTH CANADA AUTHORIZED USE OF FREESTYLE LIBRE SYSTEM IN HOSPITAL SETTING DURING COVID-19 PANDEMIC Source text for Eikon: Further company coverage: ...
FierceBiotech

FDA clears Abbott's hand-held diabetes reader for FreeStyle Libre 3 CGM

As it embarks on a widespread effort to remind users of the proper care and keeping of the hand-held readers used with its FreeStyle Libre continuous glucose monitors, Abbott is further expanding the ...